Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Diabetes Practice Patterns, Knowledge Gaps Identified
Findings presented for almost 1,000 health care providers who manage type 2 diabetes

WEDNESDAY, Feb. 13 (HealthDay News) -- Practice patterns and knowledge gaps vary for health care providers (HCPs) who manage patients with type 2 diabetes, although most patients receive evidence-based care, according to research published in the Winter issue of Clinical Diabetes.

J. Chad Williamson, of CE Outcomes in Birmingham, Ala., and colleagues surveyed 974 HCPs, including endocrinologists, family medicine physicians/primary care physicians (PCPs), internists, nurse practitioners, physician assistants, certified diabetes educators, and retail- and hospital-based pharmacists to better understand existing practice patterns and educational gaps.

The researchers observed variability between HCPs in the awareness of guidelines, comfort levels with and opinions about different insulin regimens, awareness of and opinions about incretin therapy, and knowledge of appropriate reasons for referral, although most HCPs provided evidence-based care. Barriers to diabetes management included cultural barriers, language differences, and time constraints.

"The gaps identified in this study regarding the perception, knowledge, and practice of managing patients with type 2 diabetes provide ample targets for educating HCPs involved in the care of patients with this disease," the authors write. "Reviews of the latest evidence on and guideline recommendations for type 2 diabetes management for the PCPs and allied HCPs are warranted, as well as reinforcement of the efficacy and safety data of available diabetes therapies."

The study was funded by Novo Nordisk. Two authors disclosed financial ties to the health care industry.

Abstract
Full Text



Health News Copyright © 2013 HealthDay. All rights reserved.

May 19, 2013

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

AHA: Variation in Outpatient Cardiac Risk Factor Management

Marijuana Use Tied to Lower Fasting Insulin Level, HOMA-IR

AHA: iPhone App Transmits Heart Images Quickly

Twitter Reveals Popular Health Beliefs About Acne

DSM-4 Task Force Chairman Advises Caution With DSM-5

ASCO: Midlife Fitness May Protect Against Cancer